Total Payments
$301,906
2024 Payments
$124,563
Companies
27
Transactions
968
Medicare Patients
18,487
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$165,088 (54.7%)
Travel$71,107 (23.6%)
Consulting$44,426 (14.7%)
Food & Beverage$21,106 (7.0%)
Education$178.82 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $162,888 | 142 | 54.0% |
| Travel and Lodging | $71,107 | 160 | 23.6% |
| Consulting Fee | $44,426 | 39 | 14.7% |
| Food and Beverage | $21,106 | 620 | 7.0% |
| Honoraria | $2,200 | 2 | 0.7% |
| Education | $178.82 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $133,676 | 331 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $73,663 | 157 | $0 (2024) |
| Lilly USA, LLC | $59,207 | 170 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $16,395 | 44 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $2,455 | 15 | $0 (2024) |
| LEO Pharma Inc. | $2,271 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $2,174 | 70 | $0 (2024) |
| UCB, Inc. | $1,703 | 13 | $0 (2024) |
| Eli Lilly and Company | $1,500 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,466 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124,563 | 339 | ABBVIE INC. ($76,915) |
| 2023 | $76,098 | 263 | Lilly USA, LLC ($29,347) |
| 2022 | $77,634 | 229 | ABBVIE INC. ($32,294) |
| 2021 | $23,610 | 137 | AbbVie Inc. ($13,848) |
All Payment Transactions
968 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.49 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $914.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $66.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,275.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.72 | General |
| 11/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $458.90 | General |
| 11/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $409.43 | General |
| 11/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $396.31 | General |
| 11/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $373.73 | General |
| 11/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $176.53 | General |
| 11/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $176.53 | General |
| 11/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $0.01 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 4,970 | 8,367 | $1.7M | $268,224 |
| 2022 | 32 | 5,052 | 8,982 | $1.8M | $287,026 |
| 2021 | 32 | 4,562 | 8,122 | $1.6M | $269,499 |
| 2020 | 31 | 3,903 | 6,774 | $966,651 | $211,348 |
Total Patients
18,487
Total Services
32,245
Medicare Billing
$1.0M
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,461 | 1,953 | $580,041 | $92,896 | 16.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 513 | 555 | $209,790 | $33,446 | 15.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 503 | 561 | $189,618 | $30,299 | 16.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 737 | 917 | $204,491 | $26,409 | 12.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 279 | 279 | $102,951 | $15,784 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 202 | $84,840 | $15,274 | 18.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 526 | 2,706 | $62,238 | $10,520 | 16.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 59 | 66 | $37,092 | $6,080 | 16.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 106 | 155 | $26,040 | $4,967 | 19.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 44 | 47 | $27,918 | $4,638 | 16.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 40 | 46 | $22,632 | $3,642 | 16.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $17,504 | $3,195 | 18.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 17 | $17,187 | $3,080 | 17.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 69 | 71 | $13,206 | $2,318 | 17.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 33 | 33 | $13,761 | $2,202 | 16.0% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 18 | 18 | $11,286 | $2,029 | 18.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 23 | 24 | $10,056 | $1,963 | 19.5% |
| 69100 | Biopsy of ear | Office | 2023 | 45 | 50 | $16,050 | $1,915 | 11.9% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 16 | 16 | $9,568 | $1,701 | 17.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 44 | 57 | $10,830 | $1,518 | 14.0% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 13 | 14 | $7,756 | $1,389 | 17.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 28 | 28 | $6,664 | $1,025 | 15.4% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 25 | 25 | $7,600 | $908.99 | 12.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 48 | 71 | $3,337 | $596.15 | 17.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 84 | 403 | $9,672 | $307.80 | 3.2% |
About Kirk Gautier, PAC
Kirk Gautier, PAC is a Physician Assistant healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821027798.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kirk Gautier, PAC has received a total of $301,906 in payments from pharmaceutical and medical device companies, with $124,563 received in 2024. These payments were reported across 968 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($162,888).
As a Medicare-enrolled provider, Gautier has provided services to 18,487 Medicare beneficiaries, totaling 32,245 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Athens, TX
- Active Since 07/02/2006
- Last Updated 08/04/2017
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1821027798
Products in Payments
- RINVOQ (Biological) $90,991
- Sotyktu (Drug) $53,313
- SKYRIZI (Biological) $39,003
- OLUMIANT (Drug) $17,872
- TALTZ (Drug) $15,312
- Zoryve (Drug) $7,961
- HUMIRA (Biological) $3,513
- Olumiant (Drug) $3,145
- TREMFYA (Drug) $2,189
- DUPIXENT (Biological) $1,671
- VTAMA (Drug) $1,399
- WYNZORA (Drug) $1,200
- AMELUZ (Drug) $1,085
- Cabtreo (Drug) $1,043
- COSENTYX (Drug) $418.44
- ADBRY (Biological) $308.50
- OPZELURA (Drug) $205.50
- ILUMYA (Biological) $151.91
- Otezla (Drug) $138.68
- COSENTYX (Biological) $123.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Athens
Simon Bessette, Pa-C, PA-C
Physician Assistant — Payments: $21,534
Physician Assistant $21,534
Adriana Walsh, Pa-C, PA-C
Physician Assistant — Payments: $11,402
Physician Assistant $11,402
William Retterbush, Pa-C, PA-C
Physician Assistant — Payments: $7,302
Physician Assistant $7,302
Sebastian Afonso, Pac, PAC
Physician Assistant — Payments: $6,987
Physician Assistant $6,987
Ms. Miranda Seagraves, Pa-C, PA-C
Physician Assistant — Payments: $6,563
Physician Assistant $6,563
Miss. Margaret Weckbacher, Pa-C, PA-C
Physician Assistant — Payments: $6,363
Physician Assistant $6,363